Virogates
6.5 DKK -7.14%HC Andersen Capital has previously received payment from Virogates for a Digital IR/Corporate Visibility agreement. This means that there may be paid material that is not updated. See disclaimer.
Virogates is a medical technology company. Business operations are conducted within the research and development of biomarkers and diagnostic instruments for the healthcare industry. The products are sold under various brands and are used in the identification, analysis, and further treatment of diseases, mainly cardiovascular diseases, cancer, and neurological diseases. The company was established in 2001 and is headquartered in Birkerød.
Latest videos
Financial calendar
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
N.P. Louis-Hansen APS. | 25.8 % | 25.8 % |
Kim Ginnerup APS | 10.3 % | 10.3 % |
Premium
This content is for our Premium customers only.
Resolutions from the Annual General Meeting of ViroGates A/S
ViroGates announces the outcome of its Q-Submission filing for suPARnostic® TurbiLatex with the US FDA and the overall timeline for filing a submission of a 510k/“De Novo” application with the FDA
Join Inderes community
Don't miss out - create an account and get all the possible benefits